(Total Views: 504)
Posted On: 03/31/2020 4:18:47 PM
Post# of 153903
Lorbas,
Excellent summary. Thanks.
Bottom line: Things are accelerating. We will be likely receiving lots of data (major data in NP words) here in USA and from England and Italy during the month of April.
Approval not far away (if data continues to show benefit as we all expect) !!!
Excellent summary. Thanks.
Quote:
2-3 weeks for interim/full analysis possible (Phase 2); Phase 3 interim analysis with 100 patients possibly, approval if results are good.
Bottom line: Things are accelerating. We will be likely receiving lots of data (major data in NP words) here in USA and from England and Italy during the month of April.
Approval not far away (if data continues to show benefit as we all expect) !!!
(4)
(0)
